Skip to main content

Jobs Job Match Companies People Locations Salaries Blog Resume Scanner Post a Job

Zero G Talent

Jobs
Job Match
Companies
People
Locations
Salaries
Blog
Resume Scanner
Post a Job

About
Contact
Privacy
Terms

© 2026 Zero G Talent. All rights reserved.

Home
People
Kazumi Shiosaki

Kazumi Shiosaki

Kazumi Shiosaki

CEO, Twentyeight-Seven Therapeutics

Managing Director at MPM Capital

Cambridge, Massachusetts

About

Female

Kazumi Shiosaki - Managing Director @ MPM Capital

Experience

Managing Director · 2003 – present

31Boston, Massachusetts, United StatesBiotechnology · Health Care

Board Member · Epizyme
President & CEO, Founder · Mitobridge
CEO · Twentyeight-Seven Therapeutics

Education

University of California Berkeley · Ph.D, Synthetic Chemistry
Whitman College · BS, Chemistry

People at MPM Capital

Elizabeth Stoner

Executive Partner

Ansbert Gadicke

Managing Director and Co-Founder

Data from: crunchbase

Managing Director

Briggs Morrison

Managing Director

Christiana Bardon

Co-Managing Partner

View all at MPM Capital →

Latest from Kazumi Shiosaki

Headlines from Google News. Social posts load from the platform only when you open a tab.

Looking beyond cancer, Twentyeight-Seven Therapeutics bumps up series A to $82M+
Fierce Biotech · May 10
MPM, Novartis lead a big launch round for Kazumi Shiosaki’s latest biotech startup coming out of Harvard
Endpoints News · Sep 7
Astellas Acquires Mitobridge Under Existing Collaboration
PR Newswire · Nov 30
Sanford Burnham Prebys Medical Discovery Institute Appoints Three New Members to the Board of Trustees | Newswise
newswise.com · Apr 27
Top women in biotech 2013
Fierce Biotech · Nov 26